No Record Found
No Record Found
Sector
PharmaceuticalsOpen
₹1,174.3Prev. Close
₹1,186.4Turnover(Lac.)
₹5,824.83Day's High
₹1,202.7Day's Low
₹1,162.152 Week's High
₹1,19052 Week's Low
₹716.6Book Value
₹118.3Face Value
₹1Mkt Cap (₹ Cr.)
25,339.32P/E
72.42EPS
16.38Divi. Yield
0The estimated sale value of these shares is about ₹2,500 Crore. As per reports, the transaction shall take place at a floor price of ₹860 per share.
Here are some of the stocks that may see significant price movement today: IREDA, Tata Motors, Sai Life Sciences, etc.
The IPO that was opened between December 11 and December 13, 2024 aggregates to ₹3,042.62 crore and has had a price band of ₹533-549 per equity share.
Investors can bid for up to 27 shares in a single lot, with the company setting a price range of Rs 522-549 per share.
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 20.89 | 17.66 | 17.62 | 17.23 |
Preference Capital | 0 | 0.39 | 0.39 | 0.39 |
Reserves | 2,146.58 | 993.15 | 894.72 | 873.42 |
Net Worth | 2,167.47 | 1,011.2 | 912.73 | 891.04 |
Minority Interest |
No Record Found
No Record Found
No Record Found
| Particulars (Rupees in Crores.) | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|---|
Gross Sales | 2,192.49 | 1,694.57 | 1,465.18 | 1,217.14 | 869.59 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 2,192.49 | 1,694.57 | 1,465.18 | 1,217.14 | 869.59 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 49.13 | 36.78 | 29.09 | 27.97 | 28.15 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,782.2 | 142.57 | 4,27,933.39 | 608.7 | 0.9 | 4,887.27 | 93.23 |
Divis Laboratories Ltd DIVISLAB | 6,623 | 66.04 | 1,75,833.11 | 756 | 0.45 | 2,793 | 629.49 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,420.9 | 67.6 | 1,49,548.89 | 467 | 0.86 | 2,677 | 249.73 |
Cipla Ltd CIPLA | 1,401.3 | 32.87 | 1,13,154.89 | 384.64 | 0.93 | 3,840.92 | 423.36 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,089 | 29.67 | 1,09,568.82 | 1,722 | 0.09 | 3,564.6 | 235.25 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Exec. Director
Ranga Raju Kanumuri
Managing Director & CEO
Krishnamraju Kanumuri
Independent Non Exe. Director
Ramesh Iyer
Independent Non Exe. Director
Suchita Sharma
Independent Non Exe. Director
Dinesh V Patel
Whole Time Director & CFO
SIVARAMAKRISHNAN CHITTOR
Company Sec. & Compli. Officer
RUNA KUMAR
Plot #.DS-7 IKP Knowledge Park,
Turkapally (V) Shameerpet Md,
Telangana - 500078
Tel: +91 40 6815 6000
Website: http://www.sailife.com
Email: investors@sailife.com
Karvy Selenium Tow-B,
31&32 Financial Dist, Nanakramguda,
Hyderabad-500032
Tel: 91-40-67162222
Website: www.kfintech.com
Email: einward.ris@karvy.com
Summary
Sai Life Sciences Limited was originally incorporated as Sai Dru Syn Laboratories Limited as a Public Limited Company, dated January 25, 1999, issued by the Registrar of Companies, Andhra Pradesh at H...
Read More
Reports by Sai Life Sciences Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.